These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 30826459)

  • 1. Src deficient mice demonstrate behavioral and electrophysiological alterations relevant to psychiatric and developmental disease.
    Ward KR; Featherstone RE; Naschek MJ; Melnychenko O; Banerjee A; Yi J; Gifford RL; Borgmann-Winter KE; Salter MW; Hahn CG; Siegel SJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():84-92. PubMed ID: 30826459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia.
    Banerjee A; Wang HY; Borgmann-Winter KE; MacDonald ML; Kaprielian H; Stucky A; Kvasic J; Egbujo C; Ray R; Talbot K; Hemby SE; Siegel SJ; Arnold SE; Sleiman P; Chang X; Hakonarson H; Gur RE; Hahn CG
    Mol Psychiatry; 2015 Sep; 20(9):1091-100. PubMed ID: 25330739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population.
    Featherstone RE; Shin R; Kogan JH; Liang Y; Matsumoto M; Siegel SJ
    Neurobiol Dis; 2015 Jan; 73():289-95. PubMed ID: 25461194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.
    Halene TB; Ehrlichman RS; Liang Y; Christian EP; Jonak GJ; Gur TL; Blendy JA; Dow HC; Brodkin ES; Schneider F; Gur RC; Siegel SJ
    Genes Brain Behav; 2009 Oct; 8(7):661-75. PubMed ID: 19563516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction.
    Aguilar DD; Radzik LK; Schiffino FL; Folorunso OO; Zielinski MR; Coyle JT; Balu DT; McNally JM
    Sci Rep; 2021 Apr; 11(1):9031. PubMed ID: 33907230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockout of NMDA receptors in parvalbumin interneurons recreates autism-like phenotypes.
    Saunders JA; Tatard-Leitman VM; Suh J; Billingslea EN; Roberts TP; Siegel SJ
    Autism Res; 2013 Apr; 6(2):69-77. PubMed ID: 23441094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.
    Gandal MJ; Sisti J; Klook K; Ortinski PI; Leitman V; Liang Y; Thieu T; Anderson R; Pierce RC; Jonak G; Gur RE; Carlson G; Siegel SJ
    Transl Psychiatry; 2012 Jul; 2(7):e142. PubMed ID: 22806213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.
    Balu DT; Li Y; Takagi S; Presti KT; Ramikie TS; Rook JM; Jones CK; Lindsley CW; Conn PJ; Bolshakov VY; Coyle JT
    Neuropsychopharmacology; 2016 Jul; 41(8):2052-61. PubMed ID: 26741285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvalbumin cell ablation of NMDA-R1 causes increased resting network excitability with associated social and self-care deficits.
    Billingslea EN; Tatard-Leitman VM; Anguiano J; Jutzeler CR; Suh J; Saunders JA; Morita S; Featherstone RE; Ortinski PI; Gandal MJ; Lin R; Liang Y; Gur RE; Carlson GC; Hahn CG; Siegel SJ
    Neuropsychopharmacology; 2014 Jun; 39(7):1603-13. PubMed ID: 24525709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia.
    Rowland LM; Summerfelt A; Wijtenburg SA; Du X; Chiappelli JJ; Krishna N; West J; Muellerklein F; Kochunov P; Hong LE
    JAMA Psychiatry; 2016 Feb; 73(2):166-74. PubMed ID: 26720179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
    Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
    Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?
    Gandal MJ; Anderson RL; Billingslea EN; Carlson GC; Roberts TP; Siegel SJ
    Genes Brain Behav; 2012 Aug; 11(6):740-50. PubMed ID: 22726567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced NMDA receptor tyrosine phosphorylation in PTPalpha-deficient mouse synaptosomes is accompanied by inhibition of four src family kinases and Pyk2: an upstream role for PTPalpha in NMDA receptor regulation.
    Le HT; Maksumova L; Wang J; Pallen CJ
    J Neurochem; 2006 Sep; 98(6):1798-809. PubMed ID: 16899073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
    Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-aspartate dysregulation in Ddo(-/-) mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum.
    de Bartolomeis A; Errico F; Aceto G; Tomasetti C; Usiello A; Iasevoli F
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():35-43. PubMed ID: 25979765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia-like phenotypes in mice with NMDA receptor ablation in intralaminar thalamic nucleus cells and gene therapy-based reversal in adults.
    Yasuda K; Hayashi Y; Yoshida T; Kashiwagi M; Nakagawa N; Michikawa T; Tanaka M; Ando R; Huang A; Hosoya T; McHugh TJ; Kuwahara M; Itohara S
    Transl Psychiatry; 2017 Feb; 7(2):e1047. PubMed ID: 28244984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia.
    Gulchina Y; Xu SJ; Snyder MA; Elefant F; Gao WJ
    J Neurochem; 2017 Nov; 143(3):320-333. PubMed ID: 28628228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
    Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
    Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMDA receptor-deficient mice display sexual dimorphism in the onset and severity of behavioural abnormalities.
    Milenkovic M; Mielnik CA; Ramsey AJ
    Genes Brain Behav; 2014 Nov; 13(8):850-62. PubMed ID: 25327402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking Src-PSD-95 interaction rescues glutamatergic signaling dysregulation in schizophrenia.
    Featherstone RE; Li H; Sengar A; Borgmann-Winter KE; Melnychenko O; Crown LM; Gifford RL; Amirfathi F; Banerjee A; Parekh K; Heller M; Zhang W; Marc AD; Salter MW; Siegel SJ; Hahn CG
    bioRxiv; 2024 Mar; ():. PubMed ID: 38496466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.